Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 25

1.

Chemoprevention of rat prostate carcinogenesis by soy isoflavones and by Bowman-Birk inhibitor.

McCormick DL, Johnson WD, Bosland MC, Lubet RA, Steele VE.

Nutr Cancer. 2007;57(2):184-93.

PMID:
17571952
2.
3.
4.

The Bowman-Birk inhibitor from soybeans as an anticarcinogenic agent.

Kennedy AR.

Am J Clin Nutr. 1998 Dec;68(6 Suppl):1406S-1412S. Review.

PMID:
9848508
5.

Soy isoflavones and cancer prevention.

Sarkar FH, Li Y.

Cancer Invest. 2003;21(5):744-57. Review.

PMID:
14628433
6.

Chemoprevention of prostate cancer.

Kucuk O.

Cancer Metastasis Rev. 2002;21(2):111-24. Review.

PMID:
12465750
7.

Genistein chemoprevention: timing and mechanisms of action in murine mammary and prostate.

Lamartiniere CA, Cotroneo MS, Fritz WA, Wang J, Mentor-Marcel R, Elgavish A.

J Nutr. 2002 Mar;132(3):552S-558S. Review.

8.

Soy, isoflavones, and prostate cancer.

Jian L.

Mol Nutr Food Res. 2009 Feb;53(2):217-26. doi: 10.1002/mnfr.200800167. Review.

PMID:
18985655
9.

The role of soy phytoestrogens in prostate cancer.

Holzbeierlein JM, McIntosh J, Thrasher JB.

Curr Opin Urol. 2005 Jan;15(1):17-22. Review.

PMID:
15586024
10.

Chemoprevention strategies for prostate cancer.

Bosland MC, McCormick DL, Melamed J, Walden PD, Zeleniuch-Jacquotte A, Lumey LH.

Eur J Cancer Prev. 2002 Aug;11 Suppl 2:S18-27. Review.

PMID:
12570331
11.

Development of Bowman-Birk inhibitor for chemoprevention of oral head and neck cancer.

Meyskens FL.

Ann N Y Acad Sci. 2001 Dec;952:116-23. Review.

PMID:
11795430
12.

Emerging evidence on the role of soy in reducing prostate cancer risk.

Messina MJ.

Nutr Rev. 2003 Apr;61(4):117-31. Review.

PMID:
12795445
13.

Prevention of carcinogenesis by protease inhibitors.

Kennedy AR.

Cancer Res. 1994 Apr 1;54(7 Suppl):1999s-2005s. Review.

14.

Animal models for the study of prostate carcinogenesis.

Bosland MC.

J Cell Biochem Suppl. 1992;16H:89-98. Review.

PMID:
1289679
15.

Cancer prevention by protease inhibitors.

Kennedy AR.

Prev Med. 1993 Sep;22(5):796-811. Review.

PMID:
8234219
16.

Soy isoflavones and prostate cancer: a review of molecular mechanisms.

Mahmoud AM, Yang W, Bosland MC.

J Steroid Biochem Mol Biol. 2014 Mar;140:116-32. doi: 10.1016/j.jsbmb.2013.12.010. Epub 2013 Dec 25. Review.

17.

The biochemical and functional food properties of the bowman-birk inhibitor.

Losso JN.

Crit Rev Food Sci Nutr. 2008 Jan;48(1):94-118. doi: 10.1080/10408390601177589. Review. Erratum in: Crit Rev Food Sci Nutr. 2008 Sep;48(8):798.

PMID:
18274967
18.

Soy for breast cancer survivors: a critical review of the literature.

Messina MJ, Loprinzi CL.

J Nutr. 2001 Nov;131(11 Suppl):3095S-108S. Review.

19.

Mechanisms of cancer chemoprevention by soy isoflavone genistein.

Sarkar FH, Li Y.

Cancer Metastasis Rev. 2002;21(3-4):265-80. Review.

PMID:
12549765
20.
Items per page

Supplemental Content

Write to the Help Desk